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Adprhl1, a member of the ADP-ribosylhydrolase protein family, is expressed exclusively in the developing
heart of all vertebrates. In the amphibian Xenopus laevis, distribution of its mRNA is biased towards
actively growing chamber myocardium. Morpholino oligonucleotide-mediated knockdown of all Adprhl1
variants inhibits striated myoﬁbril assembly and prevents outgrowth of the ventricle. The resulting
ventricles retain normal electrical conduction and express markers of chamber muscle differentiation but
are functionally inert. Using a cardiac-speciﬁc Gal4 binary expression system, we show that the abun-
dance of Adprhl1 protein in tadpole hearts is tightly controlled through a negative regulatory mechanism
targeting the 5′-coding sequence of Xenopus adprhl1. Over-expression of full length (40 kDa) Adprhl1
variants modiﬁed to escape such repression, also disrupts cardiac myoﬁbrillogenesis. Disarrayed myo-
ﬁbrils persist that show extensive branching, with sarcomere division occurring at the actin-Z-disc
boundary. Ultimately, Adprhl1-positive cells contain thin actin threads, connected to numerous circular
branch points. Recombinant Adprhl1 can localize to stripes adjacent to the Z-disc, suggesting a direct role
for Adprhl1 in modifying Z-disc and actin dynamics as heart chambers grow. Modelling the structure of
Adprhl1 suggests this cardiac-speciﬁc protein is a pseudoenzyme, lacking key residues necessary for
ADP-ribosylhydrolase catalytic activity.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In all vertebrate embryos, the chambers of the heart arise by
transformation of a simple, linear myocardial muscle tube. As
cardiac beating commences, this tube subsequently loops with a
counter-clockwise, helical rotation and chambers balloon out from
regions of the outer curvature. In recent years, detailed descrip-
tions of heart developmental anatomy have been produced (de
Boer et al., 2012; Mohun and Weninger, 2011; Xavier-Neto et al.,
2012) and transcription factors identiﬁed that are important for
the correct emergence of the cardiac chambers (reviewed Greulich
et al. (2011) and McCulley and Black (2012)). Nonetheless, identi-
fying the downstream mechanisms that ensure the precise con-
struction of chamber structures still present a major challenge.
Myoﬁbrillogenesis, the process of assembling the contractile
protein machinery within muscle cells of the embryonic heart,r Inc. This is an open access article
n).occurs concurrently with chamber formation. In fact, myoﬁbril
growth is intimately linked to increasing cardiomyocyte cell size
and the coordinated changes in cell shape that underpin chamber
outgrowth (Lin et al., 2012). In mouse embryos, myoﬁbrils are
known to assemble near the surface of chamber cardiomyocytes
and initially extend in diverse directions to produce multiple
junctions with neighbouring cells. As these myoﬁbrils lengthen,
they gradually acquire an increasingly parallel orientation. How-
ever, true longitudinal growth, where myoﬁbrils are fully aligned
and adjacent cells have the same polarity, only occurs during late
stages of chamber maturation. This occurs, for example, within the
ventricle compact layer observed beyond E16.5 and after birth
(Hirschy et al., 2006). Regional variations in myoﬁbril patterns also
exist within the early forming chambers. This variability goes be-
yond the obvious differences between myoﬁbril orientations in
ventricle trabeculae compared to the external free walls (Price
et al., 1996). Within the simple heart of zebraﬁsh, distinct myoﬁbril
arrangements are found in the ventricle compared to the atrium.
Moreover, pattern differences have also been noted between
ventricular myoﬁbrils residing at different depths within the sameunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sured in living embryos shows regional responses within the
ventricle; not all cardiomyocytes grow and deposit myoﬁbrils
within a monitored time frame, but those that are hypertrophic
will frequently have neighbouring cells that are also growing (Lin
et al., 2012). It seems likely that such heterogeneity in myoﬁ-
brillogenesis will be a major feature of ventricle formation in
higher vertebrates, given the added asymmetry that accompanies
outgrowth of more complex chambers. Cells must behave asyn-
chronously in order that an asymmetric structure be constructed.
In models that describe the sequence of myoﬁbrillogenesis (Liu
et al., 2013; Sparrow and Schock, 2009), rearrangement of the
actin cytoskeleton in the cell cortex is a crucial early step. This
requires disassembly, as well as ﬁlament nucleation and elonga-
tion to produce sarcomeric actin ﬁlaments with uniform length
and polarity. However, such models rarely consider the trajectory
of myoﬁbril assembly, an aspect that is critical to understanding
how embryonic cardiomyocytes are incorporated into heart
chambers; furthermore mechanisms to explain such directionality
are simply not known. It is also unclear to what extent myoﬁbrils
that have different orientations within a cell are structurally con-
nected to each other during this phase of chamber outgrowth. In
this study, we have identiﬁed a novel protein, Adprhl1, whose
action modiﬁes early cardiac actin dynamics and myoﬁbril
directionality.
Adprhl1 is so named because of its sequence similarity to a
small group of ADP-ribosylhydrolase enzymes encoded in verte-
brate genomes; Adprh (sometimes named ARH1), Adprhl1 (ARH2)
and Adprhl2 (ARH3)(pfam03747). Mono-ADP-ribosylation of pro-
teins is a post-translational modiﬁcation catalysed by ADP-ribo-
syltransferase enzymes and also many bacterial toxins (reviewed
Aktories et al. (2011) and Laing et al. (2011)). It appears to be a
reversible modiﬁcation, with ADP-ribosylhydrolase (Adprh) a 357
amino acid (in human) cytosolic protein that can cleave the ADP-
ribose linkage with arginine (protein) side chains (Moss et al.,
1985, 1992; Okazaki et al., 1995). Natural protein targets of Adprh
are unclear and while mice lacking Adprh are viable, evidence from
the knockout indicates that Adprh somehow acts as an important
tumour suppressor (Kato et al., 2011). Expression of adprh in
zebraﬁsh embryos is detected transiently within forming somites,
suggesting ADP-ribosylation might participate in skeletal muscle
development. Study of another member of this homologous gene
family, ADP-ribosylhydrolase-like 2 (Adprhl2), which shares 22%
amino acid sequence identity with Adprh, has revealed it can act
on two distinct classes of substrates. Mammalian Adprhl2 hydro-
lyzes poly(ADP-ribose) chains to release ADP-ribose monomers
(Oka et al., 2006), potentially opposing the activity of the poly
(ADP-ribose) polymerases that signal during DNA repair and
chromatin remodelling. Adprhl2 can also hydrolyze O-acetylated-
ADP-ribose (Kasamatsu et al., 2011; Ono et al., 2006), the reaction
by-product of Sir2 protein deacetylases, but does not act on mono-
ADP-ribose linked to amino acids.
ADP-ribosylhydrolase-like 1 (Adprhl1) (Oka et al., 2006) is an-
other member of this protein family, the 354 amino acid sequence
of human Adprhl1 showing 46% identity to Adprh. Intriguingly, in
contrast to the other two proteins, Adprhl1 appears to lack any
comparable enzymatic activity (Oka et al., 2006). The strong evo-
lutionary conservation of Adprhl1 sequence extends to frogs, with
Xenopus Adprhl1 being 75% identical to human Adprhl1 and 47%
identical to the Xenopus species Adprh. Here, we have studied
Adprhl1 function using embryos of the frog, Xenopus laevis. Models
of the Adprhl1 protein structure explain the lack of enzymatic
activity compared to other family members. We have identiﬁed
expression of its mRNA within actively growing heart chamber
myocardium in Xenopus embryos. Gene knockdown and over-ex-
pression experiments demonstrate Adprhl1 is essential for heartchamber outgrowth, alteration of Adprhl1 expression levels im-
pacting upon myoﬁbril assembly. Elevated Adprhl1 is associated
with disarrayed myoﬁbril patterns, contractile ﬁlaments with di-
verging orientations and prominent branches at the actin-Z-disc
boundary. Finally, we demonstrate that in normal development,
Adprhl1 production is subject to tight regulatory control, mediated
through targeting of the 5′-coding sequence of Xenopus adprhl1.2. Materials and methods
2.1. Adprhl1 gene and cDNA sequences
X. laevis adprhl1: Xenbase XB-GENE-989263. JGI X. laevis gen-
ome 7.2 scaffold 167628: 4825123-4840241. A potential second
locus Xelaev16044576m: Genome 7.2 scaffold 338390: 1306406-
1316841. cDNA NCBI MGC:82403, IMAGE:4409193. Additionally,
intron 2 genomic isoforms from the outbred animals used in the
study were sequenced (Accession GU188989, GU188990) for
morpholino design. Human ADPRHL1: NCBI Gene ID 113622. Full
length cDNA NM_138430. Shorter coding transcript NM_199162.
The full length human ADPRHL1 cDNA used IMAGE:5299214, but it
contained a sequence variation giving a Pro248His substitution.
Expression constructs therefore exchanged a PstI-SacI fragment
from the shorter clone, IMAGE:3838063, to maintain the evolu-
tionarily conserved Pro248 residue. Mouse Adprhl1: NCBI Gene ID
234072. cDNA NM_172750. Wholemount in situ hybridization
probes comprised all of the coding sequence, or from 277 to
1065bp for comparison of transgenic line activity.
2.2. Adprhl1 morpholino sequences
Morpholino oligonucleotides (Gene-Tools) were designed to
interfere with X. laevis adprhl1 RNA splicing.
Adprhl1-e2i2MO 5′-AGGCTCAGCATCTTACAAACCTTTT-3′.
Adprhl1-i2e3MO 5′-ACCTAAGAAACAACTAGAGTCACTG-3′.
Adprhl1-e2i2MOMis 5′-AAGCTAAGCATATTAAAAACATTTT-3′.
Adprhl1-i2e3MOMis 5′-AACTAAAAAACAAATAGAATCAATG-3′.
Adprhl1-ControlMOMis 5′-GATAGTTATAAGTAATTCTACCAAT-3′.
2.3. Morpholino injection into Xenopus embryos
A 32 ng dose of the splice interfering adprhl1 morpholino oli-
gonucleotides was injected at the four-cell stage, either 2 nl of a
8 ng/nl stock was injected into both dorsal blastomeres (D-2/4) or
as a control into both ventral blastomeres (V-2/4). Injection into
dorsal blastomeres distributes morpholino into cells of the form-
ing heart whereas control ventral injection distributes morpholino
into posterior-ventral portions of the tadpole. For rescue of the
adprhl1 morpholino heart defect, a 24 ng mass of morpholino was
used, combined with 240–600 pg adprhl1 RNA. Standard proce-
dures were employed (Sive et al., 2000).
2.4. Xenopus embryo analysis
Adprhl1 RT-PCR was performed on individual stage 30 embryos,
or 50 dissected stage 42 hearts, with RNA isolated in 150 μl TRIzol
reagent, DNA-free (Ambion) and SuperScriptIII Reverse Tran-
scriptase (Invitrogen). Equivalent control reactions that did not
have reverse transcriptase added were used for all embryo RNAs.
Standard procedures were used for wholemount RNA in situ hy-
bridization (Harland, 1991; Sive et al., 2000) with antisense probes
for cardiac markers (Smith et al., 2005; Smith and Mohun, 2011)
and for Xenopus ami (adipsin, Image:6933579).
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Robert Campbell kindly donated the plasmid, CMV-R-GECO1
(Addgene:32444) (Zhao et al., 2011). A pCS2-R-GECO1 plasmid was
constructed for transcription of sense RNA. Embryos were co-in-
jected with 20 ng Adprhl1-e2i2MO and 800 pg R-GECO1 RNA into
D-2/4 blastomeres. A lower 20 ng mass of morpholino was used in
this experiment to accommodate co-injection of the RNA into
embryos. Thus a reduced proportion of tadpoles developed the
complete phenotype associated with the Adprhl1-e2i2MO (20 out
of 42 tadpoles injected, 48%). For time-lapse movies, greyscale (8-
bit) images were captured using a Q-Imaging camera and Image-
Pro software at 20 frames per second for 10 s, then false coloured
using the GEM LUT within Image J software (Schneider et al.,
2012).
2.6. Adprhl1 antibody and immunocytochemistry of Xenopus hearts
The peptide sequence used to raise a polyclonal rabbit antibody
against Adprhl1 was: 248DNYDAEERDKTYKKWSSE265 (Cambridge
Research Biochemicals). The sequence derives from mouse
ADPRHL1, yet the antibody is also active against the Xenopus and
human orthologs (aa residues 249-266). Other antibodies used
were: Myosin A4.1025 (DSHB), Actin 20-33 A5060 (Sigma), Sar-
comeric α-actinin EA-53 (abcam), FLAG M2 F1804 (Sigma), HA
3F10 (Roche), NKX2-5H-114 (Santa Cruz). Fluorescent dye-con-
jugated secondary antibodies (Jackson ImmunoResearch) and
Alexa Fluor568-conjugated phalloidin (Invitrogen) were used to
visualize myoﬁbril components. Immunocytochemistry was per-
formed on whole tadpoles and subsequently the hearts were dis-
sected, mounted in 12 μl CyGEL Sustain (biostatus) and viewed
using a Zeiss LSM5-Pascal confocal or a Zeiss Axioimager micro-
scope. The confocal images of whole hearts captured 2 mm deep
optical sections. Images of myoﬁbrils were 1 mm optical sections, at
a depth 1–2 mm below the outer (apical) myocardial surface. Cell
number counts of the heart surface at stage 33 utilised cortical
ﬁlament staining to discriminate cell boundaries while stage 37
and 40 ventricles used cell nuclei counts with Image J.
2.7. Recombinant Adprhl1 proteins
DNA constructs for expression of recombinant Adprhl1 proteins
utilised solely the coding cDNAs with no endogenous untranslated
sequences present. Hybrid human-Xenopus Adprhl1 protein con-
structs were produced by utilizing restriction sites that were
present in the cDNA of one species and engineering the same site
into the second species by PCR. Sites used were Msc1 (at 157–
162 bp in Xenopus adprhl1 cds), HinDIII (at 277–282 bp in human
ADPRHL1 cds) and Sac1 (at 789–794 bp in both species cds). Gen-
eArt Strings (Invitrogen) synthesized DNA fragments were also
employed in order to achieve discrete sequence changes in some
Adprhl1 constructs (the small peptide switches and the silent
nucleotide changes). When designing artiﬁcial construct se-
quences, the Xenopus laevis codon usage table (Musto et al., 2001)
was consulted to avoid rare occurring codons.
2.8. Binary system for cardiac Adprhl1 expression using myl7:Gal4/
UAS:responder transgenes
Transgenes were incorporated into Xenopus embryos by the
sperm nuclear injection transgenesis method (Smith et al., 2006).
A binary transgene system was adopted for most cardiac over-
expression experiments, that still incorporated and allowed ana-
lysis of new adprhl1 containing transgenes in the founder gen-
eration (S. Fig. 12). A Tg[myl7:Gal4, γCrys:eCFP] driver transgenic
frog line was established and a sperm nucleus preparation wasisolated from a f1 generation male. New responder transgenes,
such as Tg[UAS:Xenopus adprhl1, γCrys:DsRed1] , were then added
to the driver line sperm in a standard transgenesis procedure.
After injection to fertilize eggs, healthy embryos were selected at
stage 28, before transgenes became active. At stage 40, tadpoles
containing both transgenes were identiﬁed by their cyan and red-
ﬂuorescent eyes and they were analyzed for Adprhl1 protein
production at stage 44. The transgenes used in the study are listed
in S. Fig. 12, while their names are abbreviated when described in
the Results section. Stable lines for key responder transgenes were
subsequently established (S. Fig. 12).
2.9. Models of Adprhl1 structure
BLAST searching the Protein Data Bank (PDB) sequences iden-
tiﬁed the template structure for model building, the crystal
structure of human ADPRH (PDB ID: 3HFW) (Kernstock et al.,
2009), which shares 47% identity with Xenopus Adprhl1. Initial
alignments were manually reﬁned to avoid indels within elements
of secondary structure. Protein structural models of human and
Xenopus Adprhl1, plus each of the hybrid proteins were built using
the program, Modeller (Sali and Blundell, 1993). Modeller uses
homology-derived restraints of dihedral angles and distances for
main-chain and side-chain atoms. Regions lacking template co-
ordinates were built by an energy function optimization approach
based on energy minimization using conjugate gradients and
molecular dynamics with simulated annealing. The stereochemical
quality of the models was assessed by QMEAN Z-scores (Benkert
et al., 2011), which ranged from 2.81 for the Xenopus model to
3.33 for the human1-52-Xenopus53-354 hybrid Adprhl1, indicating
reliable models. Each of the hybrids superposed well, with only
minor deviations in loop regions and side chain conformations
compared with the entirely human or Xenopus Adprhl1 proteins,
suggesting they would fold correctly.3. Results
3.1. Adprhl1 mRNA is expressed during heart chamber outgrowth
In Xenopus embryos, the onset of adprhl1 expression coincides
with early myocardial differentiation (Fig. 1). Wholemount in situ
hybridization detects adprhl1 mRNA in cardiac tissue from stage
29 and moreover, the greatest concentrations are found in regions
of actively growing chamber myocardium. For example, within the
central section of the heart tube during looping stages, the left side
contains abundant adprhl1 mRNA (Fig. 1B and C) and will subse-
quently contribute to the apex and anterior wall of the ventricle
(Ramsdell et al., 2006). Moreover at stage 40, both left and right
lateral sides marking the growing atrial chambers stain strongly
for adprhl1 (Fig. 1E) whereas the dorsal atrial roof contains less of
the message. Cardiac Adprhl1 expression is conserved in mammals,
with Adprhl1 mRNA detected within embryonic mouse hearts at
E11.5 and there is also preliminary evidence its expression de-
pends on the presence of the cardiac transcription factor, Nkx2-5
(S. Fig. 1).
3.2. Adprhl1 knockdown prevents heart ventricle growth and
function
We examined the effect of knocking down Xenopus adprhl1
activity using morpholino oligonucleotides (MO) that target RNA
splicing, to inhibit production of a functional mRNA. Most ex-
periments used the Adprhl1-e2i2MO morpholino but comparable
results were also obtained using an Adprhl1-i2e3MO morpholino
(S. Figs. 2 and 8C). Tadpole hearts were analyzed through a range
Fig. 1. Myocardial expression of adprhl1 in Xenopus embryos. Developmental stage series of cardiac adprhl1 mRNA expression in X. laevis embryos. A: Left-lateral view of a
stage 33 tadpole with adprhl1mRNA detected solely in the forming heart. B–E: Adprhl1 expression at stage 31 (B), stage 33 (C), stage 35 (D) and stage 40 (E). Left-lateral view
of the heart has white lines marking planes of three transverse sections for each embryo. Red arrows indicate myocardium containing high concentration of adprhl1 mRNA
while green arrows indicate areas with lesser expression. Nuclei counterstained red. Scale bars¼100 mm. OT, outﬂow tract; V, ventricle; A, atrium.
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the tubular heart, through to stage 42, when cardiac chamber
formation has occurred (and the tadpole has increased transpar-
ency). Adprhl1 knockdown produces a consistent, speciﬁc and
profound defect in embryonic cardiogenesis. Hearts that received
the adprhl1 morpholinos form with small ventricles that do not
beat, as shown at stage 40–41 (S. Fig. 3, S. Movie 1). Beyond stage
41, oedemas develop in tadpoles with impaired cardiac function(Smith et al., 2007) and this also proved to be the case for loss of
adprhl1 (S. Fig. 3).
Co-injection of morpholino along with RNA encoding the red
ﬂuorescent calcium indicator protein, R-GECO1, allowed qualita-
tive measurement of cytosolic calcium concentration changes
within the ventricular cardiomyocytes. Inert hearts caused by loss
of adprhl1 still exhibited strong calcium waves that propagated
across the ventricle, observed at stage 42 (S. Movies 2 and 3). In
Movie 1. Movies of the adprhl1 morpholino heart beat defect. Time-lapse movies
captured at 300 ms/frame, ventral views of Tg[actc1:GFP] heart ﬂuorescence of
stage 41 tadpoles after injection with Adprhl1-e2i2MO. The ﬁrst tadpole depicted is
a non-injected, stage-matched sibling control. The second tadpole was injected
with morpholino into D-2/4 blastomeres and has a completely inert heart. The
atrial region is mostly obscured by the ventricle and does exhibit some pulsing
movement. The third tadpole also contains D-2/4-morpholino and has a severe,
though partial, heart beat defect. The atria initiate a contraction that is weakly
propagated through the ventricle. The overall appearance of these tadpoles is
presented in S. Fig. 3(I–Q). Anterior is to the left. A video clip is available online.
Supplementary material related to this article can be found online at http://dx.doi.
org/10.1016/j.ydbio.2016.05.006.
Movie 2. Calcium imaging inert hearts produced by adprhl1 morpholino. Time-lapse
movie of a stage 42 tadpole that was co-injected with Adprhl1-e2i2MO and also
R-GECO1 RNA into D-2/4 blastomeres. The injection masses were 20 ng morpholino
and 800 pg RNA. Ventral view of the cardiac ventricle is displayed, anterior to left.
The small tubular heart of this tadpole is mechanically inert. Nonetheless, the red
ﬂuorescent calcium indicator protein, R-GECO1, detects an active intracellular cal-
cium wave. The wave initiates at the inﬂow region, which is positioned more
dorsally than the ventricle so appears fainter (immediately to the right of the
ventricle in the movie). It then propagates through the ventricular portion of the
looped tube (from top to bottom of movie) and outﬂow tract (left) without ap-
parent obstruction. Greyscale images were captured and false-coloured in Image J
using the GEM LUT. Movies are 10 s duration, captured at 20 frames per second and
are played back at 5 fps.Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2016.05.006.
Movie 3. Calcium imaging a control heart. Companion to S. Movie 2. Movie shows a
sibling tadpole injected with R-GECO1 RNA only. In this normal heart, the increase
in Ca2þ-mediated ﬂuorescence occurs as ventricular systole commences. The wave
propagates from the left wall of the ventricular chamber towards the right, which is
comparable to the posterior to anterior wave of a looping stage tubular heart.
Supplementary material related to this article can be found online at http://dx.doi.
org/10.1016/j.ydbio.2016.05.006.
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showed a block in electrical conduction (S. Fig. 4), indicating that
the failure in heart function induced by adprhl1 knockdown was
not due to loss of electrical impulse generation or propagation.
3.3. Adprhl1 knockdown does not affect cardiac gene expression, nor
disrupt early morphology
Expression of cardiac muscle marker mRNAs, such as myl7
(mlc2),myh6 (mhcα) and ventricularmyl3 (mlc1v) was not affected
by adprhl1 knockdown (Fig. 2) but histological analysis revealed a
profound defect in endocardium maturation in the morphants at
stage 39, with endocardial cells having a rounded morphology andno clear lumen forming within the hearts (Fig. 2M, N).
Xenopus hearts commence peristaltic beating earlier, at stage
33–34. Analysis at this stage (S. Fig. 5) showed that in the central
section, myocardial layers were comparable in both morphant and
control heart tubes. However, while the endocardial cells were
beginning to organize and form a lumen in controls, no such
structure could be identiﬁed in the morphant hearts (S. Fig. 5F, J).
Additionally, in the outﬂow tract portion, an open myocardial
trough extended anteriorly in control hearts, but was absent in the
inert, morphant hearts (S. Fig. 5E, I). Similar effects had been noted
previously in a study of a Xenopus myh6 mutant (Abu-Daya et al.,
2009), suggesting that both abnormalities may be secondary
consequences of the absence of myocardial beating.
3.4. Adprhl1 knockdown disrupts myoﬁbril assembly in the forming
ventricle
Given the profound functional defect after adprhl1 knockdown,
we examined the assembly of myoﬁbrils within the forming ven-
tricle. Three developmental stages were assayed; at stage 33 as
looping commences, stage 37, as ventricle outgrowth would nor-
mally be occurring and at stage 40, when chamber myoﬁ-
brillogenesis should be well established.
In control stage 33 heart tubes, actin ﬁlaments stained with
phalloidin had a cortical localization, while striated patterns were
already evident for muscle myosin ﬁbres (Fig. 3C, D, also S. Fig. 6E–
H) (S. Fig. 6 includes extra data for Fig. 3 hearts). While most
cardiomyocytes had an uneven, rounded shape, some early cell
movements driving looping morphogenesis had occurred. Notably,
near the apex of the presumptive ventricle, a group of cells on the
left side had elongated to form a rosette structure (Fig. 3C, D-ar-
rowheads, Fig. 3J, S. Fig. 6E, F). However, in heart tubes that re-
ceived the adprhl1 morpholino, cortical actin ﬁlaments revealed
that none of the apex cardiomyocytes had elongated (Fig. 3A, S.
Fig. 6A, C). Moreover, muscle myosin production within the same
region was delayed (Fig. 3B, S. Fig. 6B, D).
By stage 37, control ventricles contained a characteristic ar-
rangement of myoﬁbrils, with both actin and myosin now orga-
nized into striated ﬁlaments (S. Fig. 6M–P). Around the apex, larger
myoﬁbrils of the ventricle wall (S. Fig. 6N–P-coloured arrowheads)
extended perpendicularly to axes (Fig. 3K–N) running from base to
apex (perpendicular to circumference-axes imagined from inner to
outer curvature). Myoﬁbrils closer to the base of the ventricle (the
inner curvature) aligned parallel to the axes. Knockdown of
adprhl1 severely disrupted this myoﬁbril assembly. Actin ﬁlaments
remained predominantly cortical, within rounded cells (S. Fig. 6I–
L). Myosin had accumulated by stage 37 but the resulting
Fig. 2. Adprhl1 morpholino produces small, inert cardiac ventricles. A, B, E, F, I, J: Stage 39 tadpoles injected with Adprhl1-e2i2MO into D-2/4 blastomeres show detectable
expression of myl7 (mlc2, A, B), myh6 (mhcα, E, F) and myl3 (mlc1v, I, J) in their smaller cardiac ventricles. C, D, G, H, K, L: Control stage 39 tadpoles that received the same
morpholino into V-2/4 blastomeres. Left lateral views (A, C, E, G, I, K) and ventral views of heart (B, D, F, H, J, L), anterior to left. Vascular expression of ami (adipsin) is
additionally shown to demonstrate that lateral vitelline vasculature, posterior cardinal vein and intersomitic vessels form in the absence of a functional heart beat (bare VV
patches in A, E due to damage to tadpole during procedure). M, N: Representative transverse heart sections of the D-2/4-morpholino tadpole presented (A, B). O, P: Heart
sections through the control tadpole (C, D). Section planes (Sp) indicated (B, D). Scale bar¼100 mm. H, heart; V, ventricle; A, atrium; Mc, myocardium; Ec, endocardium; OT,
outﬂow tract; VV, vitelline vessel; Lv, liver.
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consistent orientation (S. Fig. 6K, L-white arrowheads). In control
hearts at stage 40, the number and width of myoﬁbrils in the
ventricle wall was increased while their principal orientation was
maintained (Fig. 3G, H, S. Fig. 6U–X). Additional structural com-
plexity developed towards the lumenal surface, where cardio-
myocytes of the forming trabeculae elongated parallel to the base
to apex axes (Fig. 3K–N). In adprhl1 morphants, short myoﬁbrils
did ultimately accumulate but there was no recovery of their
alignment within the ventricle (Fig. 3E, F, S. Fig. 6Q–T).
At the outset of cardiac morphogenesis, equivalent numbers of
cardiomyocytes were present within morphant heart tubes com-
pared to controls (Fig. 3I). However, as ventricle outgrowth pro-
ceeded, and failed in morphants, progressively fewer cells could becounted on the ventricle surface (Fig. 3I). This could result from
reduced incorporation of cells from the progenitor pool into an
inert heart but would also occur because the obvious disorder had
caused cells to be overlaid (see Fig. 2M). Other aspects of cell
structure were unaffected by the adprhl1 morpholino. Co-injecting
RNA for membrane-tagged (lyn) mCherry ﬂuorescent protein
showed no clear difference to cytoplasmic and endocytic mem-
brane structure within ventricle cardiomyocytes (S. Fig. 7). We
were not able to determine whether nascent myoﬁbrils were
correctly anchored at the cell membrane after morpholino treat-
ment. The resolution of analysis precluded an accurate assessment
of (proto)-costamere structures.
Thus in the absence of adprhl1 function, a sequence of myoﬁ-
brillogenesis defects are observed, beginning with a loss of actin
Fig. 3. Adprhl1 morpholino disrupts myoﬁbril assembly in the forming ventricle. Comparison of dissected hearts from tadpoles injected with Adprhl1-e2i2MO (A, B, E, F) into
D-2/4 blastomeres versus those containing control morpholino (C, D, G, H). Phalloidin stain of actin ﬁlaments (red) and immunocytochemistry for myosin heavy chain (green)
is presented (þDAPI nuclei-blue-F, H). S. Fig. 6 contains additional data, including higher magniﬁcation images for stage 33, 37 and stage 40 ventricles. A–D: At the onset of
cardiac looping, stage 33, left lateral view of heart tubes. (apex-white arrowheads). E–H: After outgrowth of the ventricle, stage 40 hearts (E, G) oriented with anterior surface
upwards, showing myoﬁbril patterns (arrowheads) in the ventricle wall (F, H). Scale bars¼100 mm (A, C, E, G). Scale bars¼10 mm (F, H). I: Cell number and size measurements
for the hearts depicted here and S. Fig. 6. At stage 33, cardiac looping is more advanced in the control heart but cell surface area is comparable to the morphant. At stage 37
and 40, fewer cells are present on the surface of smaller morphant ventricles. J–N: Illustrations showing normal morphology and myoﬁbril patterns in the forming ventricle.
J: Wildtype stage 33 heart tube, depicting cardiomyocytes on the left side that elongate to form a rosette structure, an early cell movement observed during looping
morphogenesis that is absent from morphants. K: A stage 40 heart ventricle, with contours (grey lines) to represent circumference-axes running from base to apex (from
inner to outer curvature). Alignment of myoﬁbrils is described relative to these axes. L–N: Simpliﬁed arrangement of myoﬁbrils at three locations within the ventricle
chamber. Myoﬁbrils near the base (inner curvature-L) orient parallel to the axes. Conversely, around the apex, the predominant orientation of larger myoﬁbrils extends
perpendicular to the axes (M), at least for cardiomyocytes on the outer (apical) surface of the chamber. At deeper positions towards the lumen, myoﬁbrils of trabecular (Tr)
cardiomyocytes align parallel to the axes (N). There is no abrupt boundary between cardiomyocytes that contain perpendicular or parallel-oriented myoﬁbrils. Moreover, the
extent of the perpendicular cells is greater on the anterior ventricle wall (left sided origin) and lesser on the posterior wall (right origin).
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prevents early cell movements during chamber outgrowth. The
defects subsequently cause wholesale failure to the architecture of
the forming ventricle.
3.5. Adprhl1 knockdown speciﬁcity conﬁrmed by Western blot and
RNA rescue experiment
Older stage 42 hearts were used to conﬁrm the activity of the
Adprhl1-e2i2MO morpholino by Western blot (antibody described
in Materials and Methods). Two Adprhl1 protein bands were
identiﬁed in control hearts; the 40 kDa. full length protein was the
predominant species but a smaller, 23 kDa. protein was also evi-
dent. Importantly, both proteins were absent from hearts that
received the adprhl1 morpholinos ( S. Fig. 8A, C). Ordinarily,
Adprhl1 protein was found within the heart at all stages of de-
velopment. However, during later larval stages and in the juvenile
and adult frog, the relative intensities of the bands were reversed
and the 40 kDa. Adprhl1 protein became the minor form (S.
Fig. 8B). The 40 kDa. Adprhl1 protein was restricted solely to heart
tissue whereas some 23 kDa. protein was additionally detected
within the tail (S. Fig. 8D). In spite of this, it is possible the 23 kDa.
protein is also a genuine Adprhl1 species, since prolonged staining
of embryos for adprhl1 mRNA did yield a faint signal in somite and
notochord tissues (S. Fig. 8E).
Because the Adprhl1-e2i2MO produced such a consistent heart
defect, it was possible to conﬁrm its speciﬁcity in rescue experi-
ments where the morpholino was co-injected with a C-terminal
HA-tagged adprhl1 RNA (S. Fig. 9). The observed rescue was far
from complete and hearts remained smaller than non-injected
controls (S. Fig. 9C, G, K). Nonetheless, ventricular beating was
frequently restored and consequently oedemas did not develop in
stage 41 tadpoles (in this experiment, 31/60 rescued tadpoles had
functional ventricles, compared with 0/53 in tadpoles that re-
ceived the morpholino only).
3.6. Modelling Adprhl1 protein structure highlights key differences
with the ADP-ribosylhydrolase active site
Our morpholino studies established that adprhl1 was essential
for proper myoﬁbril assembly in forming heart chambers but did
not indicate how it acted in this process. We speculated whether
protein structural information could reveal insights into Adprhl1
function. Within the ADP-ribosylhydrolase family (pfam03747),
crystal structures have been solved for human ADPRH (Kernstock
et al., 2009), ADPRHL2 (Mueller-Dieckmann et al., 2006) and also
DRAG, a key regulatory enzyme of nitrogen-ﬁxing bacteria (Bert-
hold et al., 2009; Li et al., 2009). We took advantage of sequence
conservation among the homologs to model the Adprhl1 protein
onto the known all-α-helical structure of human ADPRH (PDB ID:
3HFW). Both human and Xenopus Adprhl1 sequences were
threaded onto the ADPRH structure. The entire sequence could be
modelled, with no unstable domains or areas of steric conﬂict, the
human and Xenopus species proteins folding equally well. Un-
surprisingly, the resulting model illustrates how regions of ex-
tensive sequence identity between ADPRHL1 and ADPRH are
mainly located in helices within the core of the proteins that are
necessary to maintain structural integrity (S. Fig. 10).
The active site cleft in ADPRH that binds ADP-ribose has been
identiﬁed and the crystal structure was even solved in complex
with ADP. Additionally, the reaction mechanism of active ADP-ri-
bosylhydrolases relies on a pair of divalent cations, magnesium for
ADPRH and ADPRHL2, that are coordinated by aspartate residues
located in N- and C-terminal portions of the enzyme (Berthold
et al., 2009; Mueller-Dieckmann et al., 2006). Signiﬁcantly, many
amino acids present in the cleft are changed within ADPRHL1.Three of the four critical aspartates of ADPRH have been lost in
mammalian ADPRHL1 (hADPRH D56, D302, D304 lost, only D55 is
conserved), suggesting that ADPRHL1 cation binding may be
compromised. Other key residues lost include a tyrosine and ser-
ines that stabilize the adenine and ribose groups (respectively) of
ADP (hADPRH Y263, S264, S269, S270). In their place are residues that
hinder substrate binding in the cleft (hADPRHL1 D100, S128, F130,
E304) and thus it was not possible to dock ADP at the same position
in the model of ADPRHL1 (S. Fig. 10B). Of particular note is the
aspartate, D100, that could provide an alternative coordination site
for metals but whose presence interferes with the phosphate
groups of forcibly docked ADP. In the DRAG protein, the position of
ADP-ribose binding is subtly altered (PDB ID: 2WOE) (Berthold
et al., 2009), but again, using these coordinates could not accom-
modate ADP within the ADPRHL1 model (data not shown). Overall,
the model and its altered active site cleft supports a current des-
ignation of ADPRHL1 as a pseudoenzyme. It is most unlikely to
possess a direct ADP-ribosylhydrolase catalytic activity and so
further experiments were designed to explore Adprhl1 function in
the Xenopus heart.
3.7. Tight regulation of Xenopus Adprhl1 synthesis revealed by
transgenic over-expression in the heart
Despite the mRNA for adprhl1 being an abundant molecule in
embryonic hearts, Western blot analysis showed the protein to be
relatively scarce (S. Fig. 8). Similarly, immunocytochemistry of
hearts using the same antibody was not sufﬁciently sensitive to
detect endogenous Adprhl1 protein in situ (S. Fig. 11). Furthermore,
injection of adprhl1 RNA into early embryos produced surprisingly
little recombinant protein within the heart, irrespective of RNA
amount, indicating possible post-transcriptional regulation of
Adprhl1 expression.
To investigate this possibility, we developed a binary system for
transgene expression (S. Fig. 12), comprising a Tg[myl7:Gal4]
myocardial-speciﬁc driver line and new Tg[UAS:adprhl1] responder
transgenes, utilizing both the Xenopus and orthologous human
ADPRHL1 cDNAs. Signiﬁcantly, tadpoles that contain both the dri-
ver and Xenopus-species responder transgenes do not produce
detectable Adprhl1 protein in the heart, whereas those with the
human ADPRHL1 transgene always synthesize excess protein
identiﬁed using the Adprhl1 antibody (Fig. 4A–F). A similar effect
was also observed when N-terminal FLAG-tagged constructs were
employed to ensure ready detection of recombinant proteins (S.
Fig. 13A–D). The results suggest that during normal development,
Xenopus Adprhl1 protein abundance is restricted within the
forming heart and that the Xenopus transgene, consisting solely of
coding cDNA sequence, is also subject to this negative regulation.
The sequences responsible for Xenopus Adprhl1 regulation and
human ADPRHL1 production were mapped by testing constructs
that switched nucleotide sequences between the two species in
order to encode human-Xenopus hybrid proteins (S. Figs. 13 and
14). A hybrid comprising the ﬁrst 94 amino acids of human
ADPRHL1 (1-282 bp) combined with residues 95-354 of Xenopus
Adprhl1 escaped the regulation and did accumulate in transgenic
hearts (S. Fig. 13E, F). As the size of the exchanged N-terminal
sequence was further reduced (1-156 bp, 1-52 aa), so the fre-
quency of transgenic tadpoles producing detectable Adprhl1 be-
came lower (S. Fig. 14B, E, S. Table I). Ultimately, transgenes that
contain silent nucleotide changes and yet still produce a translated
protein identical to Xenopus Adprhl1 also yielded a signiﬁcant
signal in transgenic hearts (36 changes within 1-156 bp; Fig. 4G, H,
K) (69 changes in 1-282 bp; S. Fig. 14S–U). Thus the 5′-cDNA se-
quence, rather than the amino acid sequence of the protein, was
decisive for negative regulation of transgene expression.
Stable lines were established for key adprhl1 transgenes (S.
Fig. 4. Regulation of Xenopus Adprhl1 synthesis revealed by transgenic over-expression. A, B: Eight representative transgenic tadpoles that express human ADPRHL1 protein in
their hearts. Each tadpole carries the driver Tg[myl7:Gal4] transgene plus a new integration of a Tg[UAS:human ADPRHL1] responder transgene. Ventral view of stage 44
tadpoles (A) and matching ﬂuorescence image (B) shows anti-Adprhl1 immunocytochemistry (green) and phalloidin stain in the tail (red). C, D: Conversely, recombinant
Xenopus Adprhl1 protein does not accumulate in hearts, despite the sibling tadpoles containing the same driver plus a new integration of a Tg[UAS:Xenopus adprhl1]
responder transgene. E, F: Detail view of the hearts of each tadpole presented. G, H, K: Signiﬁcantly, the driver plus the Tg[UAS:Xenopus adprhl1(silent 1-156bp)] responder
containing 36 silent nucleotide changes does produce recombinant Xenopus Adprhl1. I, J, L: Non-transgenic control tadpoles that are siblings to those in (G, H, K). The
Adprhl1-peptide antibody binds at aa residues 249–266. H, heart.
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they enabled study of transgene mRNA expression within F1-
generation embryos. Importantly, irrespective of 5′-sequence, all
transgenes caused up-regulation of adprhl1 mRNA throughout the
heart, detected around stage 38 (S. Fig. 15A–L). Nonetheless, de-
spite the initial induction, by stage 43, only the human ADPRHL1
transgene maintained elevated mRNA expression. At stage 43,
tadpoles with the Xenopus-sequence transgene showed expression
identical to control hearts, while the hybrid (1-52 aa) and the si-
lent mutation transgenes produced only subtle mRNA increases (S.
Fig. 15M–V). Adprhl1 protein synthesis in the stable lines was es-
sentially the same as in founder generation animals. Excess pro-
duction was sustained beyond stage 47 for human ADPRHL1, but
was only transient for the stable lines of hybrid and silent muta-
tion transgenes (S. Fig. 16G–L).
Transgene experiments therefore suggest control of Xenopus
Adprhl1 synthesis acts at two levels during mRNA biogenesis.
During early chamber outgrowth stages, translational inhibition
can restrict Adprhl1 production, despite the presence of an
abundant mRNA pool. Later at stage 43, the abundance of these
transgene mRNAs is also affected. During normal Xenopus heart
development, it is noteworthy that stage 43 sees a reduction in
abundance of 40 kDa full length Adprhl1 relative to the smaller
23 kDa. protein species. Since the transgenes encode 40 kDa.
Adprhl1, it is possible they were also susceptible to a mechanism
that induces a switch in endogenous Adprhl1 forms.
3.8. Adprhl1 produces disarrayed myoﬁbril patterns with branches
at actin-Z-disc boundaries
Having established regulatory constraints for transgenic pro-
duction in vivo, we were able to examine the consequence of
Adprhl1 (40 kDa) over-expression within the embryonic heart.
Transgenic tadpole hearts were subjected to a detailed study of
myoﬁbril patterns, concentrating on the ventricular chamber but
also analyzing atrial, atrio-ventricular canal and outﬂow tract re-
gions. Stage 44 was chosen for analysis of founder generation
transgenics, while the stable lines permitted study of a range of
developmental stages. Comparisons were made between hearts
that produced different Adprhl1 variants: (1) human ADPRHL1,
(2) the N-terminal human-Xenopus Adprhl1 hybrids (hybrid-1-94
and hybrid-1-52 aa), (3) those hearts identiﬁed containing positive
cells for FLAG-tagged Xenopus Adprhl1 and most tellingly, (4) nat-
ural Xenopus Adprhl1 protein produced from the transgenes with
silent mutations (S. Table I, S. Fig. 12). A range of myocardial ab-
normalities was observed with, unsurprisingly, the Xenopus-spe-
cies protein giving the more extreme effect on tadpole heart
myoﬁbrils.
Hearts containing human ADPRHL1 developed normally, with
correctly proportioned chambers, outﬂow tract and identical
myoﬁbril patterns to controls, suggesting the human protein had
no interfering activity when synthesized in tadpole hearts. Con-
versely, the hybrid-1-94 aa Adprhl1 protein was associated with
speciﬁc cardiomyocyte structural changes. Within the ventricular
wall, myoﬁbrils growing with excess hybrid-1-94 aa Adprhl1
produced extensively branched, striated actin ﬁlaments (Fig. 5E,
G). The point at which sarcomeres divided was always a modiﬁed
Z-disc, as identiﬁed by the bright stripe of phalloidin-actin stain-
ing (Fig. 5G). Branched myoﬁbrils also occurred with the hybrid-1-
52 aa, the FLAG-tagged Xenopus and natural Xenopus Adprhl1
proteins. Moreover, these proteins additionally yielded some cells
with a severe myoﬁlament defect, whose prevalence was highest
with the native Xenopus Adprhl1. In these cells, phalloidin stained
circular branch points with numerous thin (non-striated) actin
ﬁlaments radiating outwards from the foci (Fig. 6C, G). The ex-
treme myoﬁlament patterns gave cells a rounded appearance andthey protruded from the ventricle surface, both outwards and in-
wards towards the lumen (S. Fig. 16A–F). Such spherical cells, ex-
cluded from the functional ventricular wall, probably represented
the culmination of the aberrant branching process observed in all
the hearts.
In the stable lines expressing hybrid and the silent mutation
transgenes, functional embryonic hearts were ultimately formed.
This occurred because these transgenes did not maintain elevated
adprhl1mRNA expression by stage 43 and so recombinant Adprhl1
protein subsequently returned to endogenous levels (S. Fig. 16G–L).
Consequently, during analysis, there was variability in Adprhl1
production by individual cells, often between adjacent cardio-
myocytes, which did allow comparison of positive and negative
regions within the same heart (Fig. 5D, F). Some founder genera-
tion tadpoles were identiﬁed that contained large numbers of
Xenopus Adprhl1-positive, spherical cardiomyocytes and these al-
ways resulted in abnormal development of the embryonic heart
chambers (S. Fig. 16E).
Increased myoﬁbril branching was recorded in all regions of the
heart, since the myl7 promoter of the driver transgene is active in
all myocardial cells and not merely biased towards the chambers.
Sarcomere divisions caused by Adprhl1 were detected in non-
chamber myocardium of the A-V canal (Fig. 6I–L) and within atrial
cells (Fig. 6M–P). Moreover, staining for sarcomeric α-actinin
conﬁrmed it localized to the branched Z-disc structures (Fig. 6L, P).
3.9. Adprhl1 can localize to cardiac sarcomeres, adjacent to the
Z-disc and to the H-zone
Recombinant Adprhl1 usually showed a widespread distribu-
tion within the cardiomyocyte. However, using detection of the
N-terminal FLAG-tagged Adprhl1, it was possible to ﬁnd cells
where Adprhl1 actually associated with the sarcomeres. In cells
where there was little actin branching (or perhaps had not yet
altered their ﬁlament structure), FLAG-tagged human ADPRHL1
and also Xenopus Adprhl1 were observed in a striated pattern
(Fig. 7). Adprhl1 localized to two clear stripes on either side of the
Z-disc (Fig. 7D, green arrowhead) and also to a diffuse stripe
marking the H-zone of the sarcomere (Fig. 7D, E, I, white arrow-
heads). These localizations, potentially representing actin bound-
aries, provide evidence that 40 kDa. Adprhl1 may alter myoﬁbril
structure through a direct action on the sarcomere.4. Discussion
We have identiﬁed adprhl1 as an important gene that acts
during cardiogenesis by performing gene knockdown and trans-
genic over-expression studies using embryos of the frog, Xenopus
laevis. The expression of adprhl1 mRNA in the embryonic Xenopus
heart is biased towards actively growing, chamber myocardium.
Moreover, cardiac expression of Adprhl1mRNA is also conserved in
mouse embryos. It has previously been observed that ADPRHL1 is
among mRNAs that are induced as human embryonic stem cells
are differentiated in vitro towards a cardiac fate (Beqqali et al.,
2006) but, until now, the function of Adprhl1 in the forming ver-
tebrate heart has never been addressed.
Our studies show that adprhl1 is a gene whose activity is es-
sential for assembly of contractile myoﬁbrils and outgrowth of the
cardiac chambers. Nonetheless, when synthesis of full length
(40 kDa) Adprhl1 is forced in tadpoles by the introduction of
transgenes, it does not simply result in production of additional
myoﬁbrils. Rather, over-expression also disrupts myoﬁbrillogen-
esis. Engineered human-Xenopus hybrid proteins cause extensive
branching of myoﬁbrils in our assay, with sarcomere division oc-
curring at the actin-Z-disc boundary. Excess native Xenopus
Fig. 5. Branched myoﬁbrils of cells over-expressing a hybrid Adprhl1 protein. A–C: Expression of a N-terminal human-Xenopus hybrid Adprhl1 protein in myocardial cells of a
stage 44 transgenic tadpole heart. The tadpole carried the driver Tg[myl7:Gal4] transgene plus a new integration of a Tg[UAS:(FLAG)hum1-94-Xen95-354 adprhl1] responder
transgene. The entire dissected heart, anterior view, is presented. A: Anti-FLAG immunocytochemistry. B: Anti-Adprhl1. C: Phalloidin actin stain. V, ventricle; OT, outﬂow
tract. Scale bar¼100 mm. D–F: The red square (A) denotes the position of higher magniﬁcation images in which cells on the left express recombinant Adprhl1 while those on
the right do not. D: Anti-FLAG. E: Phalloidin. F: Channel merge, including DAPI nuclear stain. G: Phalloidin, detail of a 13 mm green square (E) showing actin ﬁlament
branching (green arrowheads) in cells containing recombinant Adprhl1. Scale bar¼10 mm.
S.J. Smith et al. / Developmental Biology 416 (2016) 373–388 383Adprhl1 can produce even greater effects; the actin ﬁlament net-
work appears merely as thin threads connected to numerous cir-
cular branch points, or has regressed to the extent that just these
punctate dots remain visible.
The potent action of Adprhl1 on cardiomyocyte structure may
at least in part account for our ﬁnding that detection of the protein
in the developing heart is challenging and that a negative reg-
ulatory mechanism restricts its synthesis. We presume that in
normal development, either a very low level of protein is sufﬁcient
for Adprhl1 function or that a transient signal releases this control
and permits synthesis of Xenopus Adprhl1 as the heart chambers
grow.
Why does ventricle formation fail in the absence of Adprhl1?
Distinct patterns of cardiomyocyte growth deﬁne the shape of the
emerging ventricle, plus cell proliferation also occurs withinforming chambers. During the transition from a tubular heart,
cardiomyocytes in the presumptive ventricle region elongate with
unique trajectories such that they transiently appear aligned into a
rosette pattern (Fig. 3J). This early growth, which is biased to the
left side, breaks the left-right symmetry, contributes to the char-
acteristic looped shape and deﬁnes the position of the apex. Of
course, cardiomyocyte growth is tied to myoﬁbril assembly. These
chamber cells produce myoﬁbrils whose predominant orientation
will extend across the ventricle width (perpendicular to base-to-
apex axes, Fig. 3K, M). Ultimately, the embryonic ventricle's size
and form is governed by the extent of cells growing with chamber
trajectories on the outer surface, combined with successive de-
velopment of trabecular cardiomyocytes on the lumenal side.
Trabeculae myoﬁbrils orient along the ventricle length (parallel to
base-to-apex axes, Fig. 3K, N).
Fig. 6. Myoﬁlament defects caused by expression of Xenopus Adprhl1 protein. A–D: Rounded cardiomyocyte within the ventricle of a stage 42 heart, carrying Tg[myl7:Gal4]
driver and Tg[UAS:Xenopus adprhl1(silent 1-282bp)] responder transgenes. A: Merge of anti-Adprhl1, phalloidin and DAPI stains. B: Phalloidin alone. C: A 13 mm detail (green
square, A, B) showing severe myoﬁlament defects (green arrowheads) in the Adprhl1-positive cell. D: Detail of myoﬁbrils in an adjacent, control cardiomyocyte. E–H: Xenopus
Adprhl1 in cells of the proximal outﬂow tract. G: Phalloidin stain of branched ﬁlaments and circular foci (green arrowheads) in an Adprhl1-positive cell. H: Myoﬁbrils in an
adjacent cell. I–L: Branched myoﬁbrils (green arrowheads) within the atrio-ventricular canal of a stage 44 heart with the driver plus Tg[UAS:(FLAG)Xenopus adprhl1]
transgenes. I: Anti-Adprhl1. J: Phalloidin. K: 13 mm detail of phalloidin stain. L: Merge of phalloidin, anti-α-actinin and DAPI. M-P: FLAG-Xenopus Adprhl1 production in the
forming atria. Actin branch points are detected in areas of low Adprhl1 concentration (white arrowheads) but are prevalent in cells with excess recombinant Adprhl1 (green
arrowheads). The branches occur at Z-discs, labelled by α-actinin. Scale bars¼10 mm.
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Fig. 7. Adprhl1 protein can localize to the cardiac sarcomeres. A–E: Expression of human ADPRHL1 protein within a cluster of ventricular cells from a stage 48 Tg[myl7:(FLAG)
human ADPRHL1] transgenic tadpole. A: Anti-FLAG. B: Phalloidin actin stain. C: Channel merge, including DAPI. D, E: Red rectangles (A) denote the position of 22 mm lengths
of individual myoﬁbrils. Human ADPRHL1 localizes to two stripes either side of the Z-disc (green arrowheads) and to the H-zone (white arrowheads). F–I: Similar localization
of FLAG-Xenopus Adprhl1 within a cell of a stage 42 Tg[myl7:Gal4] plus Tg[UAS:(FLAG)Xenopus adprhl1] ventricle. F: Anti-FLAG. G: Phalloidin. H: Channel merge. I: Anti-FLAG,
detail of the 13 mm red square (F). Z-disc (red arrowheads). Scale bars¼10 mm.
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defects from the earliest stages of ventricle outgrowth. Actin ﬁla-
ments remain ﬁxed at the cell cortex, chamber cardiomyocytes do
not elongate and myosin synthesis is delayed, processes that are
all interlinked. It is difﬁcult to establish whether Adprhl1 acts di-
rectly on myoﬁbrils from the morpholino experiments alone, or if
cell signalling upstream fails to initiate the programme. The lo-
calization of recombinant Adprhl1 protein in transgenic hearts
does nonetheless suggest a direct action on myoﬁbrils and actin
boundaries in particular. Given the dynamics of actin ﬁbres, loss of
Adprhl1 could impair ﬁlament degradation or initiation of new
actin polymerization and conceivably yield similar myoﬁbril
deﬁcits.
Aside from the myoﬁbrillogenesis and cell polarity defects,
morphant heart tubes at stage 33 have a normal external mor-
phology and contain equivalent numbers of cardiomyocytes.
However, by stage 37 and beyond, hearts developing without
adprhl1 function become badly malformed. Myoﬁbrils that do
eventually form in the ventricle are short and disarrayed, while
their cardiomyocytes appear disordered. We believe the lower cell
numbers measured on the surface of small morphant ventricles
reﬂects a loss of structural organization of the cardiomyocytes
caused as a consequence of the earlier defects. The cumulative
effect of heart development proceeding without a working heart
beat might also prevent continued recruitment of cardiac pro-
genitors into the heart chambers.
How might regulation of Adprhl1 synthesis be achieved? Our
experiments with adprhl1 transgenes point towards translational
control occurring as the ventricle grows, while there is also evi-
dence of repression, post-stage 43, acting on adprhl1 mRNA
abundance that coincides with an apparent shift towards a smaller
Adprhl1 protein form. The mechanism targets the 5′-coding se-
quence of the Xenopus adprhl1 mRNA, since the inhibition of
transgene expression can be evaded by substituting 36 silent nu-
cleotide changes in the ﬁrst coding 156 bp. A number of the
transgenes included a 5′-inserted FLAG tag sequence that we also
suspect of subtly reducing effective targeting (S. Table I). This
might suggest the immediate sequence surrounding the transla-
tion initiating ATG to be the most critical for inhibition to occur.
However, comparing the targeted Xenopus sequence with the
human ADPRHL1 that is not regulated in the assay, there are just
two nucleotide differences in the 24 bases immediately down-
stream of the ATG (S. Fig. 12E), indicating that a larger region of 5′-
sequence is required.
In the mouse, conditional deletion of the miRNA-processing
enzyme Dicer1 in myocardial tissues does cause disarrayed myo-
ﬁbril structure and post-natal cardiac lethality (Chen et al., 2008).
However, involvement of miRNAs in control of Adprhl1 seems
unlikely, since they invariably elicit their effects by binding un-
translated regions of mRNAs. Moreover, their action tends to
modulate or ﬁne-tune gene expression levels, rather than impos-
ing an absolute block on synthesis (reviewed Espinoza-Lewis and
Wang (2012)).
Post-transcriptional regulation of gene expression can occur at
many levels, from alternative RNA splicing, mRNA transport, lo-
calization and stability, as well as translational inhibition. In the
heart, RNA binding proteins (RBP) that mediate these processes
have been shown to affect cardiogenesis (Blech-Hermoni and
Ladd, 2013). At present, much less is known regarding which
cardiac gene mRNAs are targeted and at what point during their
processing. RBPs with high expression in the heart include
Hermes, whose over-expression in Xenopus embryos causes early
defects to cardiogenesis (Gerber et al., 2002), plus Fxr1 (Huot et al.,
2005), whose action leads to translational inhibition of talin2 and
desmoplakin in mouse cardiac muscle (Whitman et al., 2011). A
further example is the Champ RNA helicase, whose expression inmouse embryos is biased towards the chamber trabeculae, but
again, target RNAs have not been identiﬁed (Liu et al., 2001). Thus,
there are many RBP candidates that can be explored as potential
mediators of Adprhl1 regulation in the forming heart.
Using the cardiac-Gal4/UAS system, expression of responder
transgenes commences upon myocardial differentiation (stage 28),
with ﬂuorescence from a GFP reporter becoming visible in the
linear heart tube (stage 32) (data not shown). This suggests that in
our over-expression experiments, the entire process of chamber
outgrowth and its associated myoﬁbrillogenesis occur in the pre-
sence of increasing concentration of 40 kDa. Adprhl1. The resulting
tadpole hearts were analyzed at stage 44, once the ventricle has
formed. At this stage, early trabecular ridges have formed and the
initially opaque Xenopus tissues have become transparent, facil-
itating improved microscopy. The appearance of unusual myoﬁbril
morphology thus reﬂects the prolonged action of Adprhl1 during
approximately three days of cardiac development.
How might over-expression of Adprhl1 cause the punctate ac-
tin patterns and myoﬁbrillar branching? One possibility is that the
structures are merely a consequence of disrupted myoﬁbrillogen-
esis. They could represent a stalled, intermediate step during re-
arrangement of the actin cytoskeleton. Alternatively, they could
result from excessive initiation (nucleation) of actin thin ﬁlament
polymerization. In current models of myoﬁbrillogenesis, the
starting points for assembly are aggregations of α-actinin and
actin (Z-bodies) that are associated with the cell membrane at
integrin adhesion sites (proto-costameres) (Sparrow and Schock,
2009). Current understanding of nucleation and initial assembly of
actin thin ﬁlaments remains incomplete. As an example, the
muscle formin, Fhod3, which has been implicated as a key nu-
cleator of actin, actually reduces actin elongation when tested in
vitro (Iskratsch et al., 2010; Taniguchi et al., 2009). Nevertheless,
we may speculate that myoﬁbril abnormalities occur because ex-
cess Adprhl1 continually supports attachment of nascent ﬁlaments
to Z-bodies, or causes defective processing so that multiple actin
ﬁlaments are allowed to elongate with differing orientations from
a maturing Z-disc. This might conceivably reﬂect a normal role for
Adprhl1 in enabling formation of the unique three-dimensional
myoﬁbril mesh that distinguishes cardiac from skeletal muscle.
A second possibility is that branched myoﬁbrils actually arise
during normal development of the cardiac chamber and that their
frequency has been increased by Adprhl1 over-expression. Evi-
dence from embryonic zebraﬁsh hearts now supports the view
that branching naturally occurs within discrete chamber regions. A
branched network of myoﬁbrils has been observed at the outer-
most surface of ventricle cardiomyocytes (Reischauer et al., 2014).
At this location, they may function to couple laterally positioned
costameres and form bridges to deeper lying contractile myoﬁ-
brils. Branches appeared transiently in the atrium, before myoﬁ-
brils were bundled together into larger, straight ﬁbres. Moreover,
branches were also reported towards the distal ends of myoﬁbrils
in zebraﬁsh ventricle trabeculae (Reischauer et al., 2014). Within
the Xenopus ventricle, trabeculae have many bifurcations as the
ridges extend from the A-V canal into the chamber apex. Thus
branching could enable myoﬁbrils to transmit contractile force
from one trabecular cardiomyocyte on to two diverging ridges.
The developing Xenopus heart offers many advantages for those
studying the link between chamber formation and myoﬁ-
brillogenesis, in terms of both its large size and relative com-
plexity. Nonetheless, a deﬁnitive atlas of cardiac myoﬁbril struc-
ture for Xenopus chambers remains to be produced. Consequently,
while our over-expression study summarises the analysis of a very
large number of transgenic hearts, the increased branching of
myoﬁbrils caused by Adprhl1 remains a qualitative observation.
One further complexity in both Xenopus and mouse hearts is
the existence of a 23 kDa. protein identiﬁed by the Adprhl1
S.J. Smith et al. / Developmental Biology 416 (2016) 373–388 387antibody, in addition to the full length 40 kDa. Adprhl1 we have
studied. Both proteins are sensitive to adprhl1 knockdown with
splice-morpholinos. However, while 40 kDa. Adprhl1 is found so-
lely in heart muscle, the 23 kDa. protein can also be detected
within the tadpole tail. The smaller protein is unlikely to be a
product of the other ADP-ribosylhydrolase family members, given
the unique sequence selected for the antibody. While its identity
has not yet been proven, it could derive from a distinct adprhl1
primary mRNA transcript or be a processed Adprhl1 fragment.
The concept of a pseudoenzyme comes from study of the large
family of protein kinases. Following duplication of a gene, evolu-
tion-driven variation has produced proteins that have lost essen-
tial residues of their catalytic active site. Hence pseudokinases
have arisen that redeploy a substrate binding activity for a new
purpose, or that associate with and modify the conformation of a
relative kinase that retains enzymatic activity (Leslie, 2013). It is a
useful comparison to make with Adprhl1. Could cardiac Adprhl1
serve to modulate the activity of Adprh or Adprhl2, or more likely,
bind to proteins that are shared targets of the active enzymes? In
some circumstances, ADP-ribosylation can alter ﬁlament protein
dynamics. Bacterial toxin ADP-ribosyltransferases are known to
target cytoskeletal proteins of infected cells and ADP-ribosylation
prevents polymerization of non-muscle actin, vimentin and des-
min ﬁlaments (Icenogle et al., 2012). ADP-ribosylated actin (at
arg177) even acts as a capping protein on existing ﬁlaments and we
ﬁnd it intriguing why muscle α-actins proved less susceptible to
modiﬁcation by toxins in these studies (Hochmann et al., 2006).
Thus an indirect role for Adprhl1 to bind proteins that are them-
selves subject to ADP-ribosylation circuits remains a distinct pos-
sibility. The different activities of Adprhl1 that contain human
sequences in our tadpole over-expression assay may be due to
altered rates of binding to such target proteins.
The precise function of Adprhl1 may emerge by studying its
potential association with the Z-disc borders, since this will offer a
list of potential protein targets. The presence of two stripes of
Adprhl1 on both sides reﬂects the symmetry within the Z-disc
(reviewed Luther (2009)), found in the anti-parallel dimers of α-
actinin and also the barbed ends of opposing actin ﬁlaments. The
additional stripe of Adprhl1 marking the H-zone could represent a
distinct association or potentially indicate an Adprhl1 binding
partner is found at both Z-disc and M-band regions. A ﬁrst step
towards identifying precise targets will be to map domains within
the Adprhl1 sequence that mediate the sarcomeric localization.Acknowledgements
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